CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,366 enrolled
Drug / intervention
Lansoprazoledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02099682
NCT02099682N/ACompleted
CompareCT.gov

Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Takeda·observational·Posted Mar 31, 2014·Updated Nov 4, 2016

In Brief

An observational study evaluating Lansoprazole for Gastric or Duodenal Ulcers. Completed, enrolled 3,366 participants.

Detailed Summary

The purpose of this study is to investigate the safety and efficacy of long-term administration of lansoprazole (Takepron) for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric or Duodenal Ulcers
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 31, 2014
Enrollment StartAug 1, 2010
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 12.3 years ago

Interventions

Lansoprazoledrug

Lansoprazole Capsules 15/ OD Tablets